Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-07-27
1995-12-05
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514282, A61K 3144
Patent
active
054729432
ABSTRACT:
This invention relates to a method of selectively enhancing the analgesic potency of morphine and other clinically used bimodally-acting opioid agonists and simultaneously attenuating development of physical dependence, tolerance and other undesirable side-effects caused by the chronic administration of said bimodally-acting opioid agonists comprising the co-administration of a bimodally-acting opioid agonist which activates inhibitory opioid receptor-mediated functions of neurons in the nociceptive (pain) pathways of the nervous system and an opioid receptor antagonist which selectively inactivates excitatory opioid receptor-mediated side-effects caused by said bimodally-acting opioid agonists. This invention further relates to a method of detoxifying and treating opiate addicts utilizing said opioid receptor antagonists, as well as to a composition comprising an excitatory opioid receptor antagonist of the invention and a bimodally-acting opioid agonist.
REFERENCES:
patent: 5075341 (1991-12-01), Mendelson et al.
patent: 5317022 (1992-05-01), Borsodi et al.
patent: 5321012 (1994-06-01), Mayer et al.
patent: 5352680 (1994-10-01), Pologhese et al.
Shen and Crain, Regulatory Peptides, in press (1993).
Shen and Crain, Brain Res., vol. 597, 74-83 (1992).
Crain and Shen, Brain Res., vol. 575, 13-24 (1992).
Wang et al., Chinese J. Pharmacol. Toxicol., vol. 6, pp. 36-40 (1992).
Qin, Chinese J. Pharmacol. Toxicol., vol. 6 (1992).
Lange, Toxicol. Applied Pharmacol., vol. 54, pp. 177-186 (1992).
Terwillinger et al., Brain Res., vol. 548, pp. 100-110 (1991).
Shen et al., Brain Res., vol. 559, pp. 130-138 (1991).
Crain and Shen, Trends Pharmacol. Sci., vol. 11, pp. 77-81 (1990).
Fujimoto et al., Neuropharmacol., vol. 29, pp. 609-617 (1990).
Shen and Crain, Brain Res., vol. 531, pp. 1-7 (1990).
Shen and Crain, Brain Res., vol. 491, pp. 227-242 (1989).
North, Trends Neurosci., vol. 9, pp. 114-117 (1986).
Magnan et al., Naunyn-Schmiedleberg's Arch. Pharmacol., vol. 319, pp. 197-205 (1982).
Lange et al., Toxicol. Applied Pharmacol., vol. 54, pp. 177-186 (1980).
Bentley and Hardy, J. Amer. Chem. Soc., vol. 89, pp. 3281-3286 (1967).
Bentley and Hardy, Proc. Chem. Soc., p. 220 (1963).
Crain Stanley M.
Shen Ke-Fei
Albert Einstein College of Medicine of Yeshiva University
Reamer James H.
LandOfFree
Method of simultaneously enhancing analgesic potency and attenua does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of simultaneously enhancing analgesic potency and attenua, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of simultaneously enhancing analgesic potency and attenua will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1374185